OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Mechanisms of Migraine: Nitric Oxide Synthase and Neuropeptides
Nazia Karsan, Helin Gosalia, Peter J. Goadsby
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11993-11993
Open Access | Times Cited: 21

Showing 21 citing articles:

Development of an innovative turn-on fluorescent probe for targeted in-vivo detection of nitric oxide in rat brain extracts as a biomarker for migraine disease
Noha N. Atia, Pakinaz Y. Khashaba, Sally A. El Zohny, et al.
Talanta (2024) Vol. 272, pp. 125763-125763
Closed Access | Times Cited: 6

Neuroimmunological effects of omega-3 fatty acids on migraine: a review
Ting‐Bin Chen, Cheng‐Chia Yang, I‐Ju Tsai, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 4

Glutamate as a Therapeutic Substrate in Migraine
Nazia Karsan, Alexandre Bastos, Peter J. Goadsby
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3023-3023
Open Access

The role of NPY signaling pathway in diagnosis, prognosis and treatment of stroke
Taotao Jiang, Ting Zheng, Rundong Li, et al.
Neuropeptides (2024) Vol. 104, pp. 102412-102412
Closed Access | Times Cited: 2

Pituitary cyclase‐activating polypeptide targeted treatments for the treatment of primary headache disorders
Nazia Karsan, Lars Edvinsson, László Vécsei, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 7, pp. 1654-1668
Open Access | Times Cited: 2

Exploring the synergistic effects of Chuanxiong rhizoma and Cyperi rhizoma in eliciting a rapid anti-migraine action based on pharmacodynamics and pharmacokinetics
Sha Wu, Ting Zhao, Linli Jin, et al.
Journal of Ethnopharmacology (2024) Vol. 335, pp. 118608-118608
Closed Access | Times Cited: 2

Exploring the Connection between Migraines and Pregnancy: The Impact of Physical Activity on Symptom Management
Milan Lacković, Milena Janković, Sladjana Mihajlovic, et al.
Medicina (2023) Vol. 60, Iss. 1, pp. 49-49
Open Access | Times Cited: 5

Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy
Nazia Karsan, Peter J. Goadsby
CNS Drugs (2024) Vol. 38, Iss. 7, pp. 533-546
Closed Access | Times Cited: 1

Efficacy and Safety of Atogepant for Preventing Chronic and Episodic Migraines: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Lucca Moreira Lopes, Artur Menegaz de Almeida, Eric Pasqualotto, et al.
Current Treatment Options in Neurology (2024) Vol. 26, Iss. 9, pp. 411-419
Closed Access | Times Cited: 1

Mechanism of Traditional Chinese Medicine in Treating Migraine: A Comprehensive Review
Q. Chen, Mina Wang, Feiyu Fu, et al.
Journal of Pain Research (2024) Vol. Volume 17, pp. 3031-3046
Open Access | Times Cited: 1

Evaluation of Dermatological and Neurological Aspects of the Relationship between Rosacea and Headaches
Merve Aygün, Turgut Şahin, Özden Şener, et al.
Diagnostics (2023) Vol. 14, Iss. 1, pp. 23-23
Open Access | Times Cited: 3

CGRP Antagonism and Ketogenic Diet in the Treatment of Migraine
Francesca Finelli, Alessia Catalano, Michele De Lisa, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 163-163
Open Access

CGRP neuropeptide levels in patients with endometriosis-related pain treated with dienogest: a comparative study
Shahla Chaichian, Ziba Dehghan Firoozabadi, Samaneh Rokhgireh, et al.
BMC Women s Health (2024) Vol. 24, Iss. 1
Open Access

Reducción de los niveles plasmáticos de CGRP en pacientes con migraña tratados con erenumab o galcanezumab
Daniel A. Garcı́a-Estévez, A. Juanatey-García, Jorge Rodríguez-Garrido, et al.
Revista de Neurología (2024) Vol. 78, Iss. 10, pp. 293-293
Closed Access

Anti‑CGRP monoclonal antibodies in resistant migraine: preliminary real-world effectiveness and clinical predictors of response at two years
Eduardo Pons-Fuster, O Lozano-Caballero, S Martín-Balbuena, et al.
International Journal of Clinical Pharmacy (2024) Vol. 46, Iss. 6, pp. 1317-1326
Closed Access

Biomarkers and Endophenotypes of Post-traumatic Headaches
Joshua Kamins, Ramin Karimi, Ann N. Hoffman, et al.
Current Pain and Headache Reports (2024)
Closed Access

Studies on Mechanisms of Development and Electrostimulation Approaches to Migraine Therapy
Anastasia Kochneva, Elena Gerasimova, Daniel Enikeev, et al.
Journal of Evolutionary Biochemistry and Physiology (2024) Vol. 60, Iss. S1, pp. S50-S66
Closed Access

Page 1

Scroll to top